make the vast body of clinical data instantly available and indispensable for fully understanding the safety and efficacy of medical treatments and devices.

Its SOHInfo service provides all available evidence from clinical trials research to certify the efficacy and safety of drugs, devices, or other therapies (for example, CER, 505(b)(2), and 510K filings); optimize due diligence; create powerful, evidence-based competitive analysis and marketing messaging; and thoroughly understand prior research before designing new clinical trials or creating new drugs or devices.

MedAware Systems databases contain all available data from published medical science research for various disease/condition areas. This massive amount of data can be analyzed in seconds. Users are able to filter and query the data however they choose in order to answer specific questions such as which treatments show the best outcome for particular cohorts, or how does drug or device x compare to drug or device with respect to various outcomes.

With millions of data points that have been meticulously extracted, organized, and standardized, the entire body of medical research literature is available at a remarkably granular level.

The Company is now providing AI-enabled surveillance of both the published literature and adverse events as reported in regulatory databases.

The company was founded in 2013 and headquartered in Broomfield, Colorado.